Naučne publikacije akademskog osoblja

NAPOMENA

Za tačnost unetih podataka o publikacijama, naučnim i umetničkim referencama odgovorni su autori.
Datum kreiranja: 08.03.2020.

Dragana Lazarevic

Dodatne informacije

  • Lični podaci

  • Datum rođenja: 28.10.1978.
  • Mesto rođenja: Niš
  • Obrazovanje

  • Fakultet: Medicinski fakultet Univerzitet u NIšu
  • Odsek / Grupa / Smer: Medicina
  • Godina diplomiranja: 2004
  • Spisak publikacija

  • Radovi u časopisima sa IMPACT faktorom:

    1. Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C,  еt al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 2013;72(5):683-693. doi: 10.1136/annrheumdis-2012-201483.  IF2 = 12,384; IF5 = 9,999


    2. Miettunen P, Pistorio A, Palmisani E, Ravelli A, Silverman E, Oliveira S, Alessio M, Cuttica R, Mihaylova D, Espada G, Pasic S, Insalaco A, Ozen S, Porras O, Sztajnbok F, Lazarevic D, Martini A, Ruperto N. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study. Ann Rheum Dis 2013; 72(9):1503-1509. doi: 10.1136/annrheumdis-2012-201937.  IF2 = 12,384; IF5 = 9,999


    3. Milenković J, Vojinović J, Debeljak M, Toplak N, Lazarević D, Avčin T, et al. Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation. Pediatr Rheumatol 2016; 14(1):39. doi: 10.1186/s12969-016-0097-1.  IF2 = 2,543; IF5 = 2,668


    4. Varnier GC, Rosina S, Ferrari C, Pistorio A, Consolaro A....., Lazarevic D et al. Development and testing of a hybrid measure of muscle strengt in juvenile dermatomyositis for use in routine care. Аrthritis Care Res (Hoboken) 2018; 70(9):1312-1319. doi: 10.1002/acr.23491. IF2 = 4,149; IF5 = 4,905


    5. Lazarević D, Nikolić I, Ratković-Janković M, Vojinović J. Outcome of juvenile idiopathic arthritis (JIA) associated uveitis in two diseases subtypes. Arch Rheumatol 2017; 32(1):26-31. doi:10.5606/ArchRheumatol.2017.6060. IF2 = 0,208; IF5 = 0,233


    6. Susic G, Vojinovic J, Vijatov Djuric G, Stevanovic D,  Lazarevic D, Djurovic N et al. The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int 2018; 38 (Suppl 1):S347–S354. doi: 10.1007/s00296-018-3972-x. IF2 = 1,952; IF5 = 1,803


    7. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Cvetković T, Sušić G, Lazarević D, Milošević V, Cvetković M, Pavlović D. Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis. Clin Rheumatol 2019; 38(1):117-124.  IF2=2. 394 IF5 =2.380 (M23ili M22)


    8. Rosina S, Consolaro A, Dijkhuizen P, Pistorio A, Varnier GC, Bovis F....Lazarevic D. et al. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis. Rheumatology 2019;58(7):1196-1205. IF2= 5.606  IF50=5.35 (M21)


    9. Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Cvetković T, Lazarević D. et al. The association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritis  Rheumatol Int 2019;39(3):551-559. IF2= 2,2  IF5= 2.056 (M23).


    10. Stamenkovic HM, Lazarevic D, Stankovic T, Vojinovic J, Lekic B, Marinkovic A, Bosic M. Linear IgA dermatosis of the childhood-Report of an amoxicillin-induced case. Dermatol Ther 2019; e13173. https://doi.org/10.1111/dth.13173   IF2 = 3.615  (M21)


    11.Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Tererii MT, Sakamoto AP...... Lazarevic D. Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. www.juvenile-scleroderma.com. Arthritis Care Res (Hoboken). 2021 Mar 30.  doi: 10.1002/acr.24609. Online ahead of print. IF2 =4.794 IF5=5.308  

  • Radovi u ostalim časopisima:

    1. Vojinović J, Lazarević D, Pejčić Lj, Ratković-Janković M, Nikolić I, Jakovljević M.   Аdvances in ultrasound application in juvenile idiopathic arthritis. Paediatr Cro 2017;61 (Supl 1):1-5


    2. Radovic J, Lazarevic D, Nikolic I, Vojinovic J. Effect of Alfacalcidol on Oxidative Stress and Disease Activity in JIA Patients. Ann Paediatr Rheum 2012; 1(2): 126-132.


    3. Vojinović J., Sušić G., Lazarević D. Diferencijalna dijagnoza artritisa dečijeg uzrasta. Predavanje po pozivu štampano u celosti. Acta rheumatologica Belgradensia 2010; Vol 40 Suppl 2: 63-67.


    4. Sušić G, Gordana Vijatov-Đurić, Lazarević D. Dijagnoza i diferencijalna dijagnoza juvenilnog idiopatskog artritisa. Predavanje po pozivu štampano u celosti. Acta rheumatologica Belgradensia 2016; Vol 46 Suppl 1: 131-134.


    5. Lazarević D. Poliartikularni artritis - Prevencija hroničnih oštećenja zglobova. Predavanje po pozivu štampano u celosti. Prev Ped 2017; Vol 3 (1-2): 21-24.


    6. Lazarević D, Milenković J, Vojinović J. Predavanje po pozivu štampano u celosti. Autoinflamatorne bolesti. Balneoclimactologia 2018; Vol 42 (1): 105-117.


    7. Lazarević D, Ratković-Janković M, Jakovljević M, Vojinović J. Dugotrajna efikasnost i bezbednost primene adalimumaba u lečenju juvenilnog idiopatskog artritisa (JIA) sa uveitisom Long term efficacy and safety of adalimumab in Juvenile Idiopathic Arthritis (JIA) associated uveitis. Acta Medica Medianae 2021 doi:10.5633/amm.2021.0304.

  • Radovi na naučnim skupovima međunarodnog značaja:

    1. Vojinovic J, Basic J, Susic G, Lazarevic D, Damjanov NImpact of FokI VDR and TNFalpha-308 Polymorphism On Disease Severity and Long Term Outcome in JIA Patients On Anti-TNF Treatment. Arthritis Rheumatism 2012; 64 (10): S495. https://acrabstracts.org/abstract/impact-of-foki-vdr-and-tnfalpha-308-polymorphism-on-disease-severity-and-long-term-outcome-in-jia-patients-on-anti-tnf-treatment/

    2. Vojinovic J, Lazarevic D, Dimic M. Vitamin D and bone mineral density in health and disease. Is vitamin D analogue treatment option in JIA? Clin Exp Rheum 2011; 29(2): 436.

    3. Lazarevic D, Golubovic EVojinovic JStankovic T. Severe atipical  Henoch-Schonlein Purpura with elements of Microscopic Polyangitis. Clin Exp Rheum 2011; 29(2): 455.

    4. Lazarevic D,  Radovic J,  Debeljak M, Toplak N,   Avcin T,   Vojinovic J.Influence of MEFV Gene Mutations and R202Q Polymorphism on Inflammatory Clinical Manifestations and Oxidative StressAnn Rheum Dis 2015; 74(Suppl 2): 841-842. DOI:10.1136/annrheumdis-2015-eular.5298.

    5. Lazarevic D, Vojinovic J. Autologous stem-cell transplantation (ASCT) as treatmet option in a child with severe systemic sclerosis. Ann Rheum Dis 2014; 73(Suppl2):1094. DOI:10.1136/annrheumdis-2014-eular.4710.

    6. Vojinovic J, Jeftovic T, Lazarevic D, Susic G. Long term outcome and FoKI VDR polimorphism in JIA patients on anti-TNF treatment. Ann Rheum Dis 2013; 72(Suppl 3):739. DOI: 10.1136/annrheumdis-2013-eular.2191

    7. Lazarevic D, Vojinovic J. Immuglobuline G4 (IGG4) Deposit Disease And Orbital Pseudotumor As First Manifestations Of Wegener's Granulomatosis (WG) In Child. Ann Rheum Dis 2012; 71(Suppl 3):681. DOI:10.1136/annrheumdis-2012-eular.749.

    8. Ferrari C, Consolaro A,Varnier G,  Rao AP, Lazarevic D, Demirkaya E, et al. Comparison of construct validity of two functional ability measures in children with juvenile dermatomyositis. Ann Rheum Dis 2012; 71(Suppl 3): 427. DOI: 10.1136/annrheumdis-2012-eular.2793.

    9. D. Lazarevic,  Vojinovic J,  Dimic A.  Vitamin D Levels And Bone Mineral Density Values In Juvenile Idiopathic Arthritis (JIA). Ann Rheum Dis 2010; 69(Suppl 3): 709. http://www.abstracts2view.com/eular/view.php?nu=EULAR10L_AB0816

    10. Lazarevic D, Vojinovic J, Susic G, et Basic J. Inflence of clinical and genetic characteristics on ability to achieve and maintain remission in JA patients on etanercept treatment. Pediatr Rheumatol Online J 2014; 12(Suppl 1): P48. DOI: 10.1186/1546-0096-12-S1-P48.

    11. Vojinovic J, Radovic J,  Lazarevic D, Jeftić-Stoimenov T, Pavlovic D. Oxidative stress in children with episodic fever of unknown origin. Pediatr Rheumatol Online J 2013; 11(Suppl 2): P215. DOI: 10.1186/1546-0096-11-S2-P215.

    12. Lazarevic D, Vojinovic JOutcome of macrophage activation syndrom (MAS) in systemic juveile idiopatic arthritis (SJIA) i i biologic trated patient. Pediatr Rheumatol Online J 2013; 11(Suppl 2): P53. DOI: 10.1186/1546-0096-11-S2-P53.

    13. Lazarevic D, Pistorio A, Miettunen P, Ravelli A, Malattia C, Clarissa Pilkington et al. The PRINTO provisional definition of remission in juvenile  dermatomyositisPediatr Rheumatol Online J 2011; 9(Suppl 1): P194. DOI: 10.1186/1546-0096-9-S1-P194.

    14. Vojinovic J, Susic G, Lazarevic D, Basic J, Nikolic I, Damjanov N. Influence of TNFα-308 and T676 TNF-RII polymorphism on response to etanercept and posibility to discotinue tretment.  Pediatr Rheumatol Online J 2011; 9(Suppl 1): P277. DOI: 10.1186/1546-0096-9-S1-P277.

    15. Varnier GC, Consolaro A, Malattia C, Rao AP, Madeo A, Demirkaya E, Lazarevic D, Civino A, Martini A, Raveli A. Development and initial validation of a new fuctional ability tool for juvenile dermatomyositisPediatr Rheumatol Online J 2011;9 (Suppl 1): P61. DOI: 10.1186/1546-0096-9-S1-P61.

    16. Lazarević D, Vojinović J, Sušić G, Damjanov N, Bašić J. DNase I levels and disease outcome in JIA patients treated with etanercept. Pediatr Rheumatol Online J 2011;9(Suppl 1): P171. DOI: 10.1186/1546-0096-9-S1-P171.

    17. Lazarević D, Vojinović J,  Sušić G, Bašić J. Influence of FOKI vitamin D receptor (VDR) and TNFα-308 tumor necrosis factor gene polymphism on long term disease outcome in juvenile idiopathic arthritis (JIA). Pediatric Rheumatology 2017, 15(Suppl 1): P269. DOI 10.1186/s12969-017-0142-8.

    18. Lazarević D, Vojinović J.  New pathogenic familiar heterozygous NLRP3 gene missence variant associated with reccurent pericardatis clinical presentation. Pediatric Rheumatology 2017, 15(Suppl 2): P185. DOI 10.1186/s12969-017-0186-9.

    19. Lazarević D, Vojinović J, Sušić G, Bašić J, Milenković J.  Contribution of vitamin D  receptor FOKI gene polymorphism on disease severity and long term disease outcome in juvenile idiopathic arthritis (JIA). XVII Mediterranean Congress of Rheumatology. Clinical Experimental Rheum, Genoa, Italia 2018, 36(1): S 79.

    20. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V,...... Lazarevic D. Update from the juvenile scleroderma inception cohort. Arthritis and Rheumatology ACR/ARHP Annual Meeting 2018; 70(59):1557-1558. https://acrabstracts.org/abstract/update-from-the-juvenile-scleroderma-inception-cohort/

    21. Lazarevic D, Vojinovic J. Tocilizumab as treatment option for achieving sustained remission in a child with takayasu arteritis. Pediatric Rheumatology 2018, 16(Suppl 2): P051. https://doi.org/10.1186/s12969-018-0265-6

    22. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V,...... Lazarevic D. Update from the juvenile scleroderma inception cohort. www.juvenile-scleroderma.com. Pediatric Rheumatology 2018, 16(Suppl 2): P270. https://doi.org/10.1186/s12969-018-0265-6

    23. Lazarevic D, Vojinovic J. AB1006 The clinical spectrum of two heterozygous mutations in the MVK gene confirming hyperimmunoglobulin D syndrome. Ann Rheum Dis 2019: 78(Suppl 2):1969.1-1969 . DOI: 10.1136/annrheumdis-2019-eular.7899.

    24. Rosina S, Varnier GC , Pistorio A , Consolaro A , Pilkington C , Maillard S,..... Lazarevic D. FRI0571 Measurement performance of reduced versions of muscle strength tools in juvenile dermatomyositis . Ann Rheum Dis 2019, 78(suppl 2):981.1-981. doi: 10.1136/annrheumdis-2019-eular.2228

    25. Foeldvari I, B. Hinrichs, Torok K, Santos MJ, Kasapcopur O, Adrovic A,...... Lazarevic D.  I Under Detection of Interstitial Lung Disease in Juvenile Systemic Sclerosis (jSSc) Utilizing Pulmonary Function Tests: Results from the Juvenile Scleroderma Inception Cohort. Arthritis and Rheumatology ACR/ARP Annual Meeting 2019: P 796. https://acrabstracts.org/abstract/under-detection-of-interstitial-lung-disease-in-juvenile-systemic-sclerosis-jssc-utilizing-pulmonary-function-tests-results-from-the-juvenile-scleroderma-inception-cohort/

    26. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V,...... Lazarevic D. Is the Presentation and Severity Different of the Juvenile Difuse and Limited Subtype Systemic Sclerosis? Results of Juvenile Scleroderma Inception Cohort. Arthritis and Rheumatology ACR/ARP Annual Meeting 2019: P 795. https://acrabstracts.org/abstract/is-the-presentation-and-severity-different-of-the-juvenile-diffuse-and-limited-subtype-systemic-sclerosis-results-of-juvenile-scleroderma-inception-cohort/

    27. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V,...... Lazarevic D. AB0967 Is there a difference in presentation of female and male patients with juvenile systemic scleroderma. an update from the juvenile systemic scleroderma inception cohort. www.juvenile-scleroderma.com. Ann Rheum Dis 2019: 78(Suppl 2):1949-1950. DOI: 10.1136/annrheumdis-2019-eular.2776

    28. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Stanevicha V,...... Lazarevic D.SAT0479 Update from the juvenile scleroderma inception cohort. www.juvenile-scleroderma.com. Ann Rheum Dis 2019: 78(Suppl 2):1720. DOI: 10.1136/annrheumdis-2019-eular.2550

    29. Foeldvari I, B. Hinrichs, Torok K, Santos MJ, Kasapcopur O, Adrovic A,...... Lazarevic D. FRI0454 Under detection of interstitial lung disease in juvenile systemic sclerosis (jssc) utilizing pulmonary function tests. results from the juvenile scleroderma inception cohort. Ann Rheum Dis 2020; 79(Suppl 1):824.1-824. DOI: 10.1136/annrheumdis-2020-eular.1788.

    30. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Terrerri MT...... Lazarevic D.THU0499 Is there a different presentation of juvenile systemic diffuse and limited subset? data from the juvenile scleroderma inception cohort. www.juvenile-scleorderma.com. Ann Rheum Dis 2020; 79(Suppl 1):487-488. DOI: 10.1136/annrheumdis-2020-eular.1667.

    31. Foeldvari I, B. Hinrichs, Torok K, Santos MJ, Kasapcopur O, Adrovic A,...... Lazarevic D. Under Detection of Interstitial Lung Disease in Juvenile Systemic Sclerosis (jSSc) Utilizing Pulmonary Function Tests. Results from the Juvenile Scleroderma Inception Cohort. Arthritis and Rheumatology ACR/ARHP Annual Meeting 2020; 70(S9):1557-1558. https://acrabstracts.org/?advanced=1&mworthyauthor=lazarevic&s=

    32. Foeldvari I,  Klotsche J,  Kasapcopur O , Adrovic A , Torok A, Terreri MT.......Lazarevic D. Is  there a different presentation of juvenile systemic diffuse and limited subset? data from the juvenile scleroderma inception cohort. www.juvenile-scleorderma.com. Pediatric Rheumatology 2018, 16(Suppl 2): 1074.

    33. Foeldvari I,  Klotsche J,  Kasapcopur O , Adrovic A , Torok A, Terreri MT.......Lazarevic D Is there a different presentation of juvenile systemic diffuse and limited subset? data from the juvenile scleroderma inception cohort. www.juvenile-scleorderma.com.  Pediatric Rheumatology 2020, 18(Suppl 2):P210. https://ped-rheum.biomedcentral.com/track/pdf/10.1186/s12969-020-00470-5.pdf

    34. 33.Lazarevic D, Jakovljevic M , Vojinovic. Long term treatment with adalimumab in Juvenile Idiopathic Arthritis associated uveitis - our experience. Pediatric Rheumatology 2020, 18(Suppl 2):P271 (e poster) https://ped-rheum.biomedcentral.com/track/pdf/10.1186/s12969-020-00470-5.pdf

    35. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Terrerri MT...... Lazarevic D. POS1304 Juvenile systemic sclerosis (jssc) patients with overlap characteristics do not have mild disease. results from the jssc inception cohort. www.juvenilescleroderma.com. Ann Rheum Dis 2021:80(suppl 1):934.1-934. DOI: 10.1136/annrheumdis-2021-eular.1613.

    36. Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Torok K, Terrerri MT...... Lazarevic D. POS0079 Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement.results from the juvenile systemic sclerosis inception cohort. www.juvenile-scleroderma.com. Ann Rheum Dis 2021, 80(suppl 1): 247.2-247. DOI: 10.1136/annrheumdis-2021-eular.799

  • Radovi na domaćim naučnim skupovima:

    1. Lazarević D. Biološki lekovi u dečjim reumatskim bolestima. XXXV republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2012.

    2. Lazarević D. Bol i otok zglobova kod dece - od simptoma do dijagnoze. XXXVI republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2013.

    3. Lazarević D. Sistemske bolesti vezivnog tkiva kod dece. XXXVII republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2015.

    4. Lazarević D. Dijagnostičke i terapijske dileme u reumatskim bolestima dece. XXXVIII republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2016.

    5. Lazarević D. Lečenje reumatskih bolesti kod dece-problemi i nedoumice. XXXIX republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2017.

    6. Lazarević D. Biološki lekovi u dečjim reumatskim bolestima. XXXX republičko savetovanje o dečjim reumatskim bolestima. Udruženje reumatologa Srbije i Institut za reumatologiju Beograd 2018.

    7. Lazarević D. Klinička prezentacija i diferencijalna dijagnoza juvenilnog idiopatskog artritisa. Pedijatrijska sekcija Srpskog lekarskog društva, Kragujevac 2018.

    8. Vojinović  J, Sušić G, Bašić J, Lazarević D, Damjanov N. Uticaj genetskog polimorfizma za TNF alpha 308 i T676G TNF-RII na ishod lečenja i mogućnost prekid anti-TNF lečenja u juvenilnom idiopatskom artritisu. Acta rheumatologica Belgradensia 2010; Vol 40 Suppl 2: 113.

    9. Vojinović  J, Lazarević D, Sušić G, Bašić -Milošević J. Uticaj FokI polimorfizma gena za vitamin D receptor (VDR) na ishod bolesti u juvenilnom idiopatskom artritisu (JIA). Acta rheumatologica Belgradensia 2013; Vol 43 Suppl 1: 97.

    10. Radović J, Lazarević D, Debeljak M, Vojinović J. Zastupljenost R202Q polimorfizma i mutacija MEFV gena i njihov uticaj na kliničke znake inflamacije u populaciji zdravih osoba u Srbiji. Acta rheumatologica Belgradensia 2014; Vol 44 Suppl 1: 60.

    11. Lazarevic D, Vojinovic J. Terapijska efikasnost i bezbednost lečenja uveitisa. Acta rheumatologica Belgradensia 2015; Vol 45 Suppl 1: 58-59.

    12. Lazarević D, Vojinović J. Efikasnost terapije Metotrexatom u obolelih od JIA, 41. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2008: 50-51.

    13. Lazarević D, Vojinović J, Sušić G, Bašić-Milošević J. Polimorfizam FokI gena za vitamin D receptor (VDR) u juvenilnom idiopatskom artritisu (JIA). 45. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2013:93.

    14. Milenković J, Lazarević D, Debeljak M, Toplak N, Avčin T, Vojinović J. Uticaj mutacija i R202Q polimorfizma MEFV gena na kliničke znake inflamacije i oksidativni stres. 46. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2015:48-49.

    15. Lazarević D, Vojinović J. Lečenje uveitisa u juvenilnom idiopatskom artritisu (JIA)-naša iskustva. 46. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2015:51.

    16. Milojević V, Lazarević D, Subotić G. Hipernatremija-terapijski algoritmi. 46. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2015:109.

    17. Nikolić I, Živanović S, Zivanović SJ, Kitić D, Ratković-Janković M , Lazarević D, Pejčić Lj. Upotreba biljnih preparata u lečenju respiratornih infekcija dece. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:69.

    18. Ratković-Janković M, Miljković P, Golubović E, Stanković S, Vučić J, Cvetković V, Kostić M, Nikolić I, Lazarević D, Paunović-Stojiljković M, Pančić D, Ristić T, Milojević D, Milošević-Anđelković Z. Ultrazvučno ispitivanje anatomskih karakteristika bubrega kod dece. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:115-116.

    19. Kostić M, Golubović E, Vojinović J, Miljković P, Ratković-Janković M, Lazarević D, Stajić S, Trajković A. Vezikoureteralni refluks  i benigni hipermobilni sindrom. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:116.

    20. Lazarević D, Vojinović J. Takayasu arteritis: dijagnostički i terapijski izazov. 48 Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2017:48-49.

    21. Jakovljević M, Lazarević D, Vojinović J. Inkompletna Kawasakijeva bolest-prikaz slučaja. 48 Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2017:49-50.

    22. Lazarević D. Poliartikularni artritis - Prevencija hroničnih oštećenja zglobova. Četvrtii godišnji kongres Udruženja za preventivnu pedijatriju Srbije (UPPS) sa međunarodnim učešćem, Zbornik apstrakata 2017:72.

    23. Lazarević D, Vojinovic J. Efikasnost primene tocilizumaba za postizanje dugotrajne remisije kod adolescentkinje sa Takayasu arteritisom. Acta rheumatologica Belgradensia 2018; Vol 48 Suppl 1: 55.

    24. Lazarevic D, Vojinovic J, Sindrom aktivacije makrofaga u sistemskom JIA –prikaz slučaja. Acta rheumatologica Belgradensia 2008, Vol 38 Suppl 1:128.

    25.  Lazarević D,  Golubović E, Vojinović E, Stanković T. Atipična purpura Hoenoch-Schonlein - prikaz slučaja. Acta rheumatologica Belgradensia 2009, Vol 39 Suppl 1:68-69.

    26. Vojinović J, Lazarević D, Dimić M, Vitamin D i vrednosti koštane gustine kod pacijenata obolelih od Juvenilnog idiopatskog artritisa, Acta rheumatologica Belgradensia 2010, Vol 40 Suppl 2 :121.

    27. Lazarević D, Vojinović J, Sušić G, Damjanov N, Bašić J. Nivo dezoksiribonukleaze I i ishod pacijenata obolelih od JIA lečenih etanerceptom. Acta rheumatologica Belgradensia 2011, Vol 41 Suppl 1: 96-97.

    28. Milojević D,Ćirić V, Milošević Z, Vučić J, Petrović Z, Perović Lj, Paunović M, Lazarević D. Izbegnuto utapanje - prikaz slučaja41. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2008: 167.

    29. Miljković P, Lazarević D, Nikolić I, Milojević D, Vučić  J, Milošević Z, Djordjević D, Stanković S, Stanković T, Živić S, Golubović E. Akutno bubrezno oštećenje u jedinici intenzivne nege, 42. Pedijatrijski Dani Srbije sa medjunarodnim učešćem,  Zbornik radova 2009:139-140.

    30. Ratković-Janković M, Miljković P, Pejčić Lj, Nikolić I, Lazarević D, Golubović E. Udruženost Nutcracker fenomena i nefrotskog sindroma kod šestogodišnje devojčice-prikaz slučaja. Prvi kongres pedijatara Srbije sa medjunarodnim učešćem, Zbornik sazetaka 2010: 213.

    31. Ratković-Janković M, Golubović E, Miljković P, Pejčic Lj, Nikolić I, Lazarević D. Procena stepena ugroženosti asfiktične novorođenčadi za razvoj akutnog oštećenja bubrega, 43. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2011: 148-149.

    32. Lazarević D, Vojinović J. Terapijski izazovi u sistemskoj sklerozi (SsC)- prikaz slučaja. Acta rheumatologica Belgradensia 2015; Vol 45 Suppl 1: 65-66.

    33. Jakovljević M, Lazarević D, Vojinović J. Hronična granulomatozna bolest kod ženskog pola-prikaz slučaja. 47. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2016:92.

    34. Lazarević D, Vojinović J, Sušić G, Bašić- Milošević J. Uticaj FokI polimorfizma gena za vitamin D receptor i TNFα-308 faktor nekroze tumora  na težinu i ishod bolesti u juvenilnom idiopatskom artritisu (JIA). Acta rheumatologica Belgradensia 2017, Vol 47 Suppl 1: 56-57.

    35. Jakovljević M, Živković N, Lazarević D, Vojinović J. Tuberkulozni meningitis – prikaz bolesnika. Treći kongres pedijatara Srbije sa medjunarodnim učešćem, Zbornik sazetaka 2018:

    36.  Lazarević D, Vojinovic J, Stamenković H, Stanković T, Ratković-Janković M, Nikolić I. Komplikacije varičele kod deteta na imunosupresivnoj  terapiji. 49. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2019: 107.

    37. 37.  Stamenković H, Lazarević D, Vojinovic J,Lekić B, Bosić M, Marinkovć A. Linearna IgA dermatoza-prikaz slučaja. 49. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2019: 109.

    38.   Ratković-Janković M, Golubović E, Pejčić Lj, Miljković P, Nakev I, Nikolić I, Lazarević D. Akutno oštećenje bubrega - dijagnostičke dileme. 49. Pedijatrijski Dani Srbije sa medjunarodnim učešćem, Zbornik radova 2019: 17-18.

Poslednji put izmenjeno sreda, 07 jul 2021 18:36